White House Office of National Drug Control Policy released its Statement of Drug Policy Priorities

 On 1 April 2025, the White House Office of National Drug Control Policy released its Statement of Drug Policy Priorities, setting out how the Trump Administration plans to tackle a drug crisis driven largely by illicit fentanyl and other synthetic substances such as methamphetamine and the adulterant xylazine. The statement is built around six priorities: cutting overdose deaths with a focus on fentanyl, securing global supply chains against trafficking, stopping drugs crossing US borders and reaching communities, preventing drug use before it starts (particularly among young people), expanding evidence-based treatment that leads to long-term recovery, and improving research and data to guide strategy.

Alongside tougher enforcement measures, including the designation of eight cartels and gangs as foreign terrorist organisations, it commits to wider access to naloxone and drug test strips, public education campaigns, and a skilled, recovery-ready workforce. Notably for the screening and testing sector, it calls for high-integrity, timely data and the use of technologies such as artificial intelligence and machine learning to modernise how information is collected and shared, and to spot emerging drug threats quickly. 

SOURCE: https://www.whitehouse.gov/wp-content/uploads/2025/04/2025-Trump-Administration-Drug-Policy-Priorities.pdf